| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.051 | 0.6 |